From Tyranny to Awakening w/ Vera Sharav | The Courtenay Turner Podcast

ByVera Sharav October 18, 2024January 20, 2025

Vera Sharav a Holocaust survivor, human rights activist, author and filmmaker joins courtenay Turner for a passionate and heartfelt discussion about her trials and tribulations and the wisdom she has gleaned. She draws parallels from her past experiences to the present time as a warning to us all in hope that personal agency will act as a disruptor to the looming tyrannical forces.

Watch the video on Rumble here.

AHRP Speaks Out

AHRP Comments on Landmark Decision by the Court of Appeals of Maryland
August 20, 2001November 21, 2014

A landmark decision by Maryland’s highest court, the Court of Appeals of Maryland, is a victory for the human rights of children. The decision affirms the responsibility of parents, the government, researchers and institutional review boards (IRB) to protect children from non-therapeutic experiments that may put their health at risk.

Read More AHRP Comments on Landmark Decision by the Court of Appeals of Maryland
AHRP Speaks Out

AHRP: Published NIMH Funded Prozac Trial Report Concealed Suicide Attempts by Teens
June 22, 2004November 21, 2014

Recent revelations indicate that pharmaceutical companies have selectively reported partial (favorable) clinical trial results from pediatric antidepressant trials and concealed evidence of harm from physicians, other health care professionals, and the public. It is universally agreed in the literature that failure to disclose all trial results compromises physicians’ ability to provide professional care – thereby increasing the likelihood of causing preventable harm. More generally, failure to disclose trial results in scientific publications taints the scientific literature (by rendering it not credible) and, as New York State Attorney General Elliot Spitzer charged recently, constitutes plain and simple fraud.

Read More AHRP: Published NIMH Funded Prozac Trial Report Concealed Suicide Attempts by Teens
AHRP Speaks Out

Memorandum in Opposition to California AB 2328
June 10, 2002November 21, 2014

REASONS FOR OPPOSITION:

Researchers would not be required to first try approved treatments, if any exist, before entering the patient into a medical experiment that may be "risky."

Researchers would not be required to consult with an independent medical expert, a non-researcher who would consider the patient’s best medical interests as paramount.

Researchers would not be required to disclose their own professional and financial interests deriving from the experiment.

Researchers would not be required to fully disclose to the patient’s family what happened to other patients who had already participated in the experiment.

Read More Memorandum in Opposition to California AB 2328
AHRP Speaks Out | Clinical Trials | Corrupt Practices | Corrupt Public Health | Corrupted Science | Current Medical Atrocities | Eugenics / Bioethics | Eugenics & Medical Atrocities | Immoral Experiments | Informed Consent | Medical Atrocities | Medical Ethics - Human Rights | Medical Research Ethics | Miscellaneous | Nazi Medical Atrocities | Nuremberg Code | Presentations by AHRP/Board Members | Presentations of Interest | Unethical Experiments | Vera Sharav, AHRP Board Member | Vulnerable Groups

The Nuremberg 75 Speeches
August 20, 2022October 19, 2022

The Nuremberg 75 Speeches *Download the Nuremberg Code at Nuremberg75.com and use it as a protective defense against anyone who tries to coerce you into being injected or exposed to any medical product or intervention that you do not freely consent to. Holocaust Survivor Vera Sharav’s Speech at Nuremberg 75…

Read More The Nuremberg 75 Speeches
Presentations of Interest

Separating Science from Promotion, Evidence from Propaganda WCSJ 2009
July 5, 2009

Click here for Separating Science from Promotion, Evidence from Propaganda

Read More Separating Science from Promotion, Evidence from Propaganda WCSJ 2009
AHRP Speaks Out

FDA: Regulatory Protections for Children
August 6, 2001November 21, 2014

Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP

To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration, Dockets Management Branch (HFA-305) Food and Drug Administration

Re: COMMENT ON: Docket #00N-0074 April 24, 2001 Interim Rule: "Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products

Excerpt: The FDA rightly chose not to permit the section 46.408 (c) waiver by IRBs of parental or guardian permission, as it leaves the specific circumstances for such a violation of parental rights to the discretion of local Institutional Review Boards (IRB). Given the stream of revelations of gross ethical and procedural violations at one after another of the nation’s premier research institutions, assumptions that “procedural safeguards are in place,” or that IRBs can be relied upon to make decisions that protect the best interests of human subjects – adults and children – has been debunked.

Read More FDA: Regulatory Protections for Children

Watch the video on Rumble here.

Similar Posts